Kollmann Katrin, Uusi-Rauva Kristiina, Scifo Enzo, Tyynelä Jaana, Jalanko Anu, Braulke Thomas
Department of Biochemistry, Children's Hospital, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Biochim Biophys Acta. 2013 Nov;1832(11):1866-81. doi: 10.1016/j.bbadis.2013.01.019. Epub 2013 Feb 9.
Neuronal ceroid lipofuscinoses (NCL) comprise a group of inherited lysosomal disorders with variable age of onset, characterized by lysosomal accumulation of autofluorescent ceroid lipopigments, neuroinflammation, photoreceptor- and neurodegeneration. Most of the NCL-related genes encode soluble and transmembrane proteins which localize to the endoplasmic reticulum or to the endosomal/lysosomal compartment and directly or indirectly regulate lysosomal function. Recently, exome sequencing led to the identification of four novel gene defects in NCL patients and a new NCL nomenclature currently comprising CLN1 through CLN14. Although the precise function of most of the NCL proteins remains elusive, comprehensive analyses of model organisms, particularly mouse models, provided new insight into pathogenic mechanisms of NCL diseases and roles of mutant NCL proteins in cellular/subcellular protein and lipid homeostasis, as well as their adaptive/compensatorial regulation at the transcriptional level. This review summarizes the current knowledge on the expression, function and regulation of NCL proteins and their impact on lysosomal integrity. This article is part of a Special Issue entitled: The Neuronal Ceroid Lipofuscinoses or Batten Disease.
神经元蜡样脂褐质沉积症(NCL)是一组遗传性溶酶体疾病,发病年龄各异,其特征为溶酶体中自荧光蜡样脂色素的蓄积、神经炎症、光感受器和神经变性。大多数与NCL相关的基因编码定位于内质网或内体/溶酶体区室的可溶性和跨膜蛋白,它们直接或间接调节溶酶体功能。最近,外显子组测序在NCL患者中鉴定出四个新的基因缺陷,以及一个新的NCL命名法,目前包括CLN1至CLN14。尽管大多数NCL蛋白的确切功能仍不清楚,但对模式生物,特别是小鼠模型的全面分析,为NCL疾病的致病机制以及突变NCL蛋白在细胞/亚细胞蛋白质和脂质稳态中的作用,及其在转录水平的适应性/补偿性调节提供了新的见解。本综述总结了目前关于NCL蛋白的表达、功能和调节及其对溶酶体完整性影响的知识。本文是名为:神经元蜡样脂褐质沉积症或巴顿病的特刊的一部分。